Researchers at the Icahn School of Medicine at Mount Sinai have identified the mechanism of action of a treatment for ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

American Cancer Society: “What causes non-small cell lung cancer?” “Oncogenes and tumor suppressor genes.” National Institutes of Health Genetics Home Reference: “Lung cancer.” ...

The FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t ...

This study suggests that immunotherapy may not be the optimal ... New, Rare Type of Small Cell Lung Cancer Identified Sep. 11, 2024 — A team of doctors and researchers have identified a new ...

Lung cancer is the third most common cancer and the leading cause of cancer-related deaths in the U.S., and according to the ...

Most lung cancers are called non-small cell lung cancer (NSCLC ... Instead, lung cancer is usually discovered because it causes symptoms. Doctors make their final diagnosis after examining ...

Whilst a persistent cough and coughing up blood is a sign something is wrong, another symptom that's often forgotten about is ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...

The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...

More than 80% of patients with lung cancer receive care in their communities, but this can leave them vulnerable to gaps in care quality and delivery. Amivantamab's role in non–small cell lung ...